7 authorised products containing Cobicistat, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| EVOTAZ 300 mg/150 mg film-coated tablets EU/1/15/1025/001-002 |
Atazanavir, Cobicistat | Bristol-Myers Squibb Pharma EEIG | — |
| Genvoya 150 mg/150 mg/200 mg/10 mg film-coated tablets EU/1/15/1061/001-002 |
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir alafenamide fumarate | Gilead Sciences Ireland UC | — |
| Genvoya 90 mg/90 mg/120 mg/6 mg film-coated tablets EU/1/15/1061/003-004 |
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir alafenamide, Tenofovir alafenamide fumarate | Gilead Sciences Ireland UC | — |
| REZOLSTA 675 mg/150 mg film-coated tablets EU/1/14/967/002 |
Darunavir ethanolate, Cobicistat | Janssen-Cilag International NV | — |
| REZOLSTA 800 mg/150 mg film-coated tablets EU/1/14/967/001 |
Darunavir, Cobicistat | Janssen-Cilag International NV | — |
| Stribild 150 mg/150 mg/200 mg/245 mg film-coated tablets EU/1/13/830/001 |
Emtricitabine, Tenofovir disoproxil, Cobicistat, Elvitegravir | Gilead Sciences Ireland UC | — |
| Symtuza 800 mg/150 mg/200 mg/10 mg film-coated tablets EU/1/17/1225/001 |
Tenofovir alafenamide, Darunavir ethanolate, Emtricitabine, Cobicistat | Janssen-Cilag International NV | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.